Search for content, post, videos

Recipharm receives approval for acquisition of Nitin


Further to the company’s announcement on 20th October 2015 that Recipharm will acquire a majority stake (74%) in Nitin Lifesciences Limited, the Indian Foreign Investment and Promotion Board has now granted approval for this transaction to take place.

Closing is expected to take place by the end of Q1 2016.